A Structural Basis for BRD2/4-Mediated Host Chromatin Interaction and Oligomer Assembly of Kaposi Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus LANA Proteins

PLoS Pathogens

Volumn 9, Issue 10, 2013, Pages

  Hellert, Jan ^a   Weidner Glunde, Magdalena ^b   Krausze, Joern ^a   Richter, Ulrike ^b   Adler, Heiko ^c   Fedorov, Roman ^b   Pietrek, Marcel ^b   Rückert, Jessica ^b   Ritter, Christiane ^a   Schulz, Thomas F ^b   Lührs, Thorsten ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BET PROTEIN; EPSTEIN BARR VIRUS ANTIGEN 1; LATENCY ASSOCIATED NUCLEAR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CHROMATIN STRUCTURE; DNA BINDING; FIELD FLOW FRACTIONATION; GAMMAHERPESVIRINAE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOPRECIPITATION; MOUSE; MUTAGENESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN INTERACTION; SEQUENCE ALIGNMENT; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION; WESTERN BLOTTING; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTIGENS, VIRAL; CHROMATIN; CRYSTALLOGRAPHY, X-RAY; HEK293 CELLS; HELA CELLS; HERPESVIRUS 8, HUMAN; HUMANS; MICE; NUCLEAR PROTEINS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN-SERINE-THREONINE KINASES; RHADINOVIRUS; SPLEEN; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS; VIRAL PROTEINS; VIRUS LATENCY;

EID: 84887302337     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003640     Document Type: Article

References (80)

1. Schulz TF, (2006) The pleiotropic effects of Kaposi's sarcoma herpesvirus. J Pathol 208: 187-198.
2. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, et al. (1999) Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A 96: 4546-4551.
3. Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, et al. (1997) The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71: 5915-5921.
4. Garber AC, Hu J, Renne R, (2002) Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. JBiolChem 277: 27401-27411.
5. Hu J, Garber AC, Renne R, (2002) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. JVirol 76: 11677-11687.
6. Lim C, Sohn H, Lee D, Gwack Y, Choe J, (2002) Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. J Virol 76: 10320-10331.
7. Komatsu T, Ballestas ME, Barbera AJ, Kelley-Clarke B, Kaye KM, (2004) KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence. Virology 319: 225-236.
8. Rawlins DR, Milman G, Hayward SD, Hayward GS, (1985) Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42: 859-868.
9. Chiang CM, Dong G, Broker TR, Chow LT, (1992) Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins. J Virol 66: 5224-5231.
10. Remm M, Brain R, Jenkins JR, (1992) The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res 20: 6015-6021.
11. Ye F, Lei X, Gao SJ, (2011) Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation. Adv Virol 2011.
12. Garber AC, Shu MA, Hu J, Renne R, (2001) DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75: 7882-7892.
13. Krithivas A, Young DB, Liao G, Greene D, Hayward SD, (2000) Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol 74: 9637-9645.
14. An FQ, Compitello N, Horwitz E, Sramkoski M, Knudsen ES, et al. (2005) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest. J Biol Chem 280: 3862-3874.
15. Friborg J Jr, Kong W, Hottiger MO, Nabel GJ, (1999) p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402: 889-894.
16. Radkov SA, Kellam P, Boshoff C, (2000) The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6: 1121-1127.
17. Renne R, Barry C, Dittmer D, Compitello N, Brown PO, et al. (2001) Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75: 458-468.
18. Verma SC, Borah S, Robertson ES, (2004) Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J Virol 78: 10348-10359.
19. Ballestas ME, Chatis PA, Kaye KM, (1999) Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284: 641-644.
20. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, et al. (1996) The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2: 918-924.
21. Szekely L, Kiss C, Mattsson K, Kashuba E, Pokrovskaja K, et al. (1999) Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin- associated nuclear bodies. J Gen Virol 80 (Pt 11) (): 2889-2900.
22. Barbera AJ, Chodaparambil JV, Kelley-Clarke B, Joukov V, Walter JC, et al. (2006) The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311: 856-861.
23. Kelley-Clarke B, Ballestas ME, Komatsu T, Kaye KM, (2007) Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes. Virology 357: 149-157.
24. Kelley-Clarke B, Ballestas ME, Srinivasan V, Barbera AJ, Komatsu T, et al. (2007) Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding. J Virol 81: 4348-4356.
25. Krithivas A, Fujimuro M, Weidner M, Young DB, Hayward SD, (2002) Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J Virol 76: 11596-11604.
26. Ottinger M, Christalla T, Nathan K, Brinkmann MM, Viejo-Borbolla A, et al. (2006) Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest. J Virol 80: 10772-10786.
27. Platt GM, Simpson GR, Mittnacht S, Schulz TF, (1999) Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J Virol 73: 9789-9795.
28. You J, Srinivasan V, Denis GV, Harrington WJ Jr, Ballestas ME, et al. (2006) Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. J Virol 80: 8909-8919.
29. You J, Croyle JL, Nishimura A, Ozato K, Howley PM, (2004) Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117: 349-360.
30. Lee AY, Chiang CM, (2009) Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability. J Biol Chem 284: 2778-2786.
31. McPhillips MG, Oliveira JG, Spindler JE, Mitra R, McBride AA, (2006) Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J Virol 80: 9530-9543.
32. Schweiger MR, You J, Howley PM, (2006) Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J Virol 80: 4276-4285.
33. Wang X, Li J, Schowalter RM, Jiao J, Buck CB, et al. (2012) Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication. PLoS Pathog 8: e1003021.
34. Simas JP, Efstathiou S, (1998) Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol 6: 276-282.
35. Speck SH, Virgin HW, (1999) Host and viral genetics of chronic infection: a mouse model of gamma-herpesvirus pathogenesis. Curr Opin Microbiol 2: 403-409.
36. Fowler P, Marques S, Simas JP, Efstathiou S, (2003) ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. J Gen Virol 84: 3405-3416.
37. Habison AC, Beauchemin C, Simas JP, Usherwood EJ, Kaye KM, (2012) Murine gammaherpesvirus 68 LANA acts on terminal repeat DNA to mediate episome persistence. J Virol 86: 11863-11876.
38. Moorman NJ, Willer DO, Speck SH, (2003) The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J Virol 77: 10295-10303.
39. Paden CR, Forrest JC, Tibbetts SA, Speck SH, (2012) Unbiased mutagenesis of MHV68 LANA reveals a DNA-binding domain required for LANA function in vitro and in vivo. PLoS Pathog 8: e1002906.
40. Ottinger M, Pliquet D, Christalla T, Frank R, Stewart JP, et al. (2009) The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters. J Virol 83: 4423-4434.
41. Ponstingl H, Henrick K, Thornton JM, (2000) Discriminating between homodimeric and monomeric proteins in the crystalline state. Proteins 41: 47-57.
42. Bochkarev A, Barwell JA, Pfuetzner RA, Bochkareva E, Frappier L, et al. (1996) Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA. Cell 84: 791-800.
43. Hegde RS, Androphy EJ, (1998) Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism. J Mol Biol 284: 1479-1489.
44. Hegde RS, Grossman SR, Laimins LA, Sigler PB, (1992) Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature 359: 505-512.
45. Han SJ, Hu J, Pierce B, Weng Z, Renne R, (2010) Mutational analysis of the latency-associated nuclear antigen DNA-binding domain of Kaposi's sarcoma-associated herpesvirus reveals structural conservation among gammaherpesvirus origin-binding proteins. J Gen Virol 91: 2203-2215.
46. Lin YJ, Umehara T, Inoue M, Saito K, Kigawa T, et al. (2008) Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4. Protein Sci 17: 2174-2179.
47. Lyskov S, Gray JJ, (2008) The RosettaDock server for local protein-protein docking. Nucleic Acids Res 36: W233-238.
48. Kedes DH, Lagunoff M, Renne R, Ganem D, (1997) Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest 100: 2606-2610.
49. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, et al. (1996) Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348: 1133-1138.
50. Avolio-Hunter TM, Frappier L, (1998) Mechanistic studies on the DNA linking activity of Epstein-Barr nuclear antigen 1. Nucleic Acids Res 26: 4462-4470.
51. Mackey D, Sugden B, (1999) The linking regions of EBNA1 are essential for its support of replication and transcription. Mol Cell Biol 19: 3349-3359.
52. Koepsel RR, Khan SA, (1986) Static and initiator protein-enhanced bending of DNA at a replication origin. Science 233: 1316-1318.
53. Stenzel TT, Patel P, Bastia D, (1987) The integration host factor of Escherichia coli binds to bent DNA at the origin of replication of the plasmid pSC101. Cell 49: 709-717.
54. Wong LY, Wilson AC, (2005) Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces a strong bend on binding to terminal repeat DNA. J Virol 79: 13829-13836.
55. Mattsson K, Kiss C, Platt GM, Simpson GR, Kashuba E, et al. (2002) Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions. J Gen Virol 83: 179-188.
56. Piolot T, Tramier M, Coppey M, Nicolas JC, Marechal V, (2001) Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J Virol 75: 3948-3959.
57. Lim C, Choi C, Choe J, (2004) Mitotic chromosome-binding activity of latency-associated nuclear antigen 1 is required for DNA replication from terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus. J Virol 78: 7248-7256.
58. Viejo-Borbolla A, Kati E, Sheldon JA, Nathan K, Mattsson K, et al. (2003) A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin. J Virol 77: 7093-7100.
59. Garcia-Gutierrez P, Mundi M, Garcia-Dominguez M, (2012) Association of bromodomain BET proteins with chromatin requires dimerization through the conserved motif B. J Cell Sci 125: 3671-3680.
60. Kanno T, Kanno Y, Siegel RM, Jang MK, Lenardo MJ, et al. (2004) Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. Mol Cell 13: 33-43.
61. Studier FW, (2005) Protein production by auto-induction in high density shaking cultures. Protein Expr Purif 41: 207-234.
62. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221.
63. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132.
64. Strong M, Sawaya MR, Wang S, Phillips M, Cascio D, et al. (2006) Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 103: 8060-8065.
65. DiMaio F, Terwilliger TC, Read RJ, Wlodawer A, Oberdorfer G, et al. (2011) Improved molecular replacement by density- and energy-guided protein structure optimization. Nature 473: 540-543.
66. Pervushin K, Ono A, Fernandez C, Szyperski T, Kainosho M, et al. (1998) NMR scalar couplings across Watson-Crick base pair hydrogen bonds in DNA observed by transverse relaxation-optimized spectroscopy. Proc Natl Acad Sci U S A 95: 14147-14151.
67. Salzmann M, Pervushin K, Wider G, Senn H, Wuthrich K, (1999) [13C]-constant-time [15N,1H]-TROSY-HNCA for sequential assignments of large proteins. J Biomol NMR 14: 85-88.
68. Salzmann M, Wider G, Pervushin K, Wuthrich K, (1999) Improved sensitivity and coherence selection for [15N,1H]-TROSY elements in triple resonance experiments. J Biomol NMR 15: 181-184.
69. Dehner A, Furrer J, Richter K, Schuster I, Buchner J, et al. (2003) NMR chemical shift perturbation study of the N-terminal domain of Hsp90 upon binding of ADP, AMP-PNP, geldanamycin, and radicicol. Chembiochem 4: 870-877.
70. van Dijk M, Bonvin AM, (2009) 3D-DART: a DNA structure modelling server. Nucleic Acids Res 37: W235-239.
71. Grundhoff A, Ganem D, (2003) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. J Virol 77: 2779-2783.
72. Glenn M, Rainbow L, Aurade F, Davison A, Schulz TF, (1999) Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. J Virol 73: 6953-6963.
73. Adler H, Messerle M, Wagner M, Koszinowski UH, (2000) Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol 74: 6964-6974.
74. Borst E-M, Pósfai György, Pogoda Frank, Messerle Martin, (2004) Mutagenesis of Herpesvirus BACs by Allele Replacement. Methods in Molecular Biology pp. 269-279.
75. Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, et al. (2006) CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7: R100.
76. Otsu N, (1979) A threshold selection method from gray-level histograms. IEEE Trans SysMan Cyber 9: 62-66.
77. Adler H, Messerle M, Koszinowski UH, (2001) Virus reconstituted from infectious bacterial artificial chromosome (BAC)-cloned murine gammaherpesvirus 68 acquires wild-type properties in vivo only after excision of BAC vector sequences. J Virol 75: 5692-5696.
78. Flach B, Steer B, Thakur NN, Haas J, Adler H, (2009) The M10 locus of murine gammaherpesvirus 68 contributes to both the lytic and the latent phases of infection. J Virol 83: 8163-8172.
79. Weinberg JB, Lutzke ML, Alfinito R, Rochford R, (2004) Mouse strain differences in the chemokine response to acute lung infection with a murine gammaherpesvirus. Viral Immunol 17: 69-77.
80. Vaerman JL, Saussoy P, Ingargiola I, (2004) Evaluation of real-time PCR data. J Biol Regul Homeost Agents 18: 212-214.